Literature DB >> 34294706

Structure of the mini-RNA-guided endonuclease CRISPR-Cas12j3.

Arturo Carabias1, Anders Fuglsang1, Piero Temperini1, Tillmann Pape1,2, Nicholas Sofos1, Stefano Stella1,3, Simon Erlendsson1,4, Guillermo Montoya5.   

Abstract

CRISPR-Cas12j is a recently identified family of miniaturized RNA-guided endonucleases from phages. These ribonucleoproteins provide a compact scaffold gathering all key activities of a genome editing tool. We provide the first structural insight into the Cas12j family by determining the cryoEM structure of Cas12j3/R-loop complex after DNA cleavage. The structure reveals the machinery for PAM recognition, hybrid assembly and DNA cleavage. The crRNA-DNA hybrid is directed to the stop domain that splits the hybrid, guiding the T-strand towards the catalytic site. The conserved RuvC insertion is anchored in the stop domain and interacts along the phosphate backbone of the crRNA in the hybrid. The assembly of a hybrid longer than 12-nt activates catalysis through key functional residues in the RuvC insertion. Our findings suggest why Cas12j unleashes unspecific ssDNA degradation after activation. A site-directed mutagenesis analysis supports the DNA cutting mechanism, providing new avenues to redesign CRISPR-Cas12j nucleases for genome editing.
© 2021. The Author(s).

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34294706     DOI: 10.1038/s41467-021-24707-3

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  42 in total

Review 1.  CRISPR-mediated adaptive immune systems in bacteria and archaea.

Authors:  Rotem Sorek; C Martin Lawrence; Blake Wiedenheft
Journal:  Annu Rev Biochem       Date:  2013-03-11       Impact factor: 23.643

2.  Cardiologists send up a trial balloon in new efforts to relieve heart failure.

Authors:  M F Goldsmith
Journal:  JAMA       Date:  1987-01-16       Impact factor: 56.272

3.  [Considerations on present-day anesthesia. 4].

Authors:  C L Hewer
Journal:  Cah Anesthesiol       Date:  1971 Jul-Sep

4.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

5.  CRISPR-CasΦ from huge phages is a hypercompact genome editor.

Authors:  Patrick Pausch; Basem Al-Shayeb; Ezra Bisom-Rapp; Connor A Tsuchida; Zheng Li; Brady F Cress; Gavin J Knott; Steven E Jacobsen; Jillian F Banfield; Jennifer A Doudna
Journal:  Science       Date:  2020-07-17       Impact factor: 47.728

6.  Clades of huge phages from across Earth's ecosystems.

Authors:  Basem Al-Shayeb; Rohan Sachdeva; Lin-Xing Chen; Fred Ward; Patrick Munk; Audra Devoto; Cindy J Castelle; Matthew R Olm; Keith Bouma-Gregson; Yuki Amano; Christine He; Raphaël Méheust; Brandon Brooks; Alex Thomas; Adi Lavy; Paula Matheus-Carnevali; Christine Sun; Daniela S A Goltsman; Mikayla A Borton; Allison Sharrar; Alexander L Jaffe; Tara C Nelson; Rose Kantor; Ray Keren; Katherine R Lane; Ibrahim F Farag; Shufei Lei; Kari Finstad; Ronald Amundson; Karthik Anantharaman; Jinglie Zhou; Alexander J Probst; Mary E Power; Susannah G Tringe; Wen-Jun Li; Kelly Wrighton; Sue Harrison; Michael Morowitz; David A Relman; Jennifer A Doudna; Anne-Catherine Lehours; Lesley Warren; Jamie H D Cate; Joanne M Santini; Jillian F Banfield
Journal:  Nature       Date:  2020-02-12       Impact factor: 49.962

7.  CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity.

Authors:  Janice S Chen; Enbo Ma; Lucas B Harrington; Maria Da Costa; Xinran Tian; Joel M Palefsky; Jennifer A Doudna
Journal:  Science       Date:  2018-02-15       Impact factor: 47.728

8.  RNA-programmed genome editing in human cells.

Authors:  Martin Jinek; Alexandra East; Aaron Cheng; Steven Lin; Enbo Ma; Jennifer Doudna
Journal:  Elife       Date:  2013-01-29       Impact factor: 8.140

9.  Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells.

Authors:  Benjamin P Kleinstiver; Shengdar Q Tsai; Michelle S Prew; Nhu T Nguyen; Moira M Welch; Jose M Lopez; Zachary R McCaw; Martin J Aryee; J Keith Joung
Journal:  Nat Biotechnol       Date:  2016-06-27       Impact factor: 54.908

10.  Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein.

Authors:  Winston X Yan; Shaorong Chong; Huaibin Zhang; Kira S Makarova; Eugene V Koonin; David R Cheng; David A Scott
Journal:  Mol Cell       Date:  2018-03-15       Impact factor: 17.970

View more
  3 in total

Review 1.  Alternative functions of CRISPR-Cas systems in the evolutionary arms race.

Authors:  Prarthana Mohanraju; Chinmoy Saha; Peter van Baarlen; Rogier Louwen; Raymond H J Staals; John van der Oost
Journal:  Nat Rev Microbiol       Date:  2022-01-06       Impact factor: 60.633

Review 2.  Structural biology of CRISPR-Cas immunity and genome editing enzymes.

Authors:  Joy Y Wang; Patrick Pausch; Jennifer A Doudna
Journal:  Nat Rev Microbiol       Date:  2022-05-13       Impact factor: 78.297

Review 3.  A Critical Review: Recent Advancements in the Use of CRISPR/Cas9 Technology to Enhance Crops and Alleviate Global Food Crises.

Authors:  Adnan Rasheed; Rafaqat Ali Gill; Muhammad Umair Hassan; Athar Mahmood; Sameer Qari; Qamar U Zaman; Muhammad Ilyas; Muhammad Aamer; Maria Batool; Huijie Li; Ziming Wu
Journal:  Curr Issues Mol Biol       Date:  2021-11-11       Impact factor: 2.976

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.